New Treatment Paradigms: Alfapump-Alfapump

Video Transcription

Video Summary

Dr. Katherine Lucero presents the Alpha Pump, a novel FDA-approved implantable device for managing recurrent or refractory ascites in liver cirrhosis patients. Dr. Jasmohan Bajaj highlights that ideal candidates are those who are not suitable for TIPS (transjugular intrahepatic portosystemic shunt) or liver transplantation, emphasizing the need for a coordinated care team. The Alpha Pump transfers ascites fluid from the abdomen to the bladder, improving quality of life and nutritional status compared to repeated paracentesis. While complications like infections, AKI, and device malfunction are possible, meticulous patient selection, perioperative antibiotic prophylaxis, and follow-up can mitigate risks. The device requires patient and caregiver engagement for maintenance. Long-term survival is comparable to TIPS, but the pump serves as a palliative treatment rather than curative. Dr. Bajaj stresses careful patient counseling, the importance of local expertise, and multidisciplinary collaboration for successful outcomes with the Alpha Pump in managing complex liver disease cases.

Keywords

Alpha Pump

ascites management

liver cirrhosis

implantable device

multidisciplinary care